Skip to content

Influence of milk as compared to soy phospholipids on risk factors for cardiovascular disease

Influence of milk as compared to soy phospholipids on risk factors for cardiovascular disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00003125
Enrollment
62
Registered
2011-06-09
Start date
2011-01-26
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E78.9

Interventions

Group 1: Daily consumption of 250 mL milk, enriched with 3 g milk phospholipids, during 7 weeks Group 2: Daily consumption of 250 mL milk, enriched with 3 g soy phospholipids, during 7 weeks

Sponsors

Max Rubner-Institut Bundesforschungsinstitut für Ernährung und Lebensmittel
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
50 Years to 76 Years

Inclusion criteria

Inclusion criteria: Overweight male volunteers, age 50- 76 years, non-smokers; written informed consent

Exclusion criteria

Exclusion criteria: - fasting glucose levels >120 mg/dl - Known metabolic or gastro-intestinal diseases, which affect the absorption, metabolism or excretion of food or food components; - Known allergy against milk or soy components - intake of supplements which might affect the parameters tested - intake of drugs which might affect the parameters tested - intestinal tract surgery or corticoid steroid treatment within the last 3 months - Inability to understand and to comply with the study protocol; - unusually high consumption of milk or dairy products - occurrence of acute gastrointestinal disorders during intervention - Occurrence of other unexpected events with relevance for the study outcome - withdrawal of consent to participate

Design outcomes

Primary

MeasureTime frame
Ratio of total zu HDL-cholesterol in serum (after 7 weeks)

Secondary

MeasureTime frame
Further parameters of lipid metabolism(triglycerides, LDL-cholesterol), glucose metabolism (glucose, insulin), hepatic metabolism (GOT, GGT, GPT), thiol metabolism (glutathione, homocysteine), inflammation (CRP, endothelial adhesion molecules) and body composition after 7 weeks intervention

Countries

Germany

Contacts

Public ContactAnne Weiland

Max Rubner-Institut Bundesforschungsinstitut für Ernährung und Lebnsmittel

studienzentrum@mri.bund.de0721 6625349

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026